Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery: A Retrospective Multi-center Study (EarlyLC-RW)
The goal of this observational study is to evaluate the efficacy and long-term clinical outcomes of early-stage lung cancer patients who have received surgery using the real-world data. The main questions it aims to answer are: * What is the best surgical strategy for patients with early-stage lung cancer? * What are the risk factors for early-stage lung cancer? Participants will receive surgery and the study will analyze the real-world data.
• Aged between 18 and 85;
• Did not receive neoadjuvant therapy before surgery;
• No history of radiation therapy;
• Eastern Cooperative Oncology Group (ECOG) score is 0-1;
• Have complete clinically relevant information including imaging data;
• All patients underwent relevant preoperative examinations;
• Stage I lung cancer (International Association for the Study of Lung Cancer/The Union for International Cancer Control staging eighth edition);